Studies on histaminergic compounds. IV: Non-isosterism between the imidazole, guanidino and isothiourea moieties at the H₂-receptorJAN STERK, G; VAN DER GOOT, H; TIMMERMAN, H et al.Archiv der Pharmazie (Weinheim). 1986, Vol 319, Num 12, pp 1057-1064, issn 0365-6233Article

Proceedings/Evolving perspectives on parenteral H₂-receptor antagonist therapy, symposium, Tucson A2, April 10-11, 1987PEURA, D. A; FRESTON, J. W.The American journal of medicine. 1987, Vol 83, Num 6, issn 0002-9343, 88 p., suppl. AConference Proceedings

Histamine-2-receptor antagonists in gastro-oesophageal refluxCOLIN-JONES, D. G.Gut. 1989, Vol 30, Num 10, pp 1305-1308, issn 0017-5749Article

Pharmacokinetics of cimetidine in humansCHERRUAULT, Y; SARIN, V. B.International journal of bio-medical computing. 1986, Vol 18, Num 2, pp 123-130, issn 0020-7101Article

Studies on the active molecular species of the H₂ receptor antagonists cimetidine and mifentidineHAAKSMA, E. E. J; RADEMAKER, B; KRAMER, K et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 1, pp 208-211, issn 0022-2623Article

Proceedings/Famotidine: clinical applications of a new H₂-receptor antagonist, symposium, May 16, 1986, Cormel, CACLINTON TEXTER, E. JR.The American journal of medicine. 1986, Vol 81, Num 4B, issn 0002-9343, 64 p.Conference Proceedings

Inhibition of acetylcholinesterase by histamine agonists and antagonistsLEE, H. S; CHEAH, L. S; GWEE, M. C. E et al.Clinical and experimental pharmacology and physiology. 1985, Vol 12, Num 6, pp 613-620, issn 0305-1870Article

Marked healing-promoting action of cimetidine on acetic acid-induced ulcer in rats with a limited food-intaking-timeITO, M; TSUKAHARA, T; SUZUKI, Y et al.Japanese journal of pharmacology. 1986, Vol 41, Num 2, pp 260-262, issn 0021-5198Article

Proceedings/Symposium on famotidine: further developments in H₂-receptor antagonist therapy: 8th. world congresses of gastroenterology, São Paulo, Brazil, 12 September 1986TEXTER, E. C. JR; MIYOSHI, A; OKABE, H et al.Scandinavian journal of gastroenterology. Supplement. 1987, Vol 22, Num 134, issn 0085-5928, 62 p.Conference Proceedings

Determination of ranitidine in a biological material by using differential pulse adsorptive stripping voltammetryALTINÖZ, S; ÖZER, D; TEMIZER, A et al.Analytical letters. 1992, Vol 25, Num 1, pp 111-118, issn 0003-2719Article

Rapid and efficient purification of cimetropium bromide and mifentidine drug metabolite mixtures derived from microsomal incubates for analysis by mass spectrometryKAJBAF, M; JAHANSHAHI, M; PATTICHIS, K et al.Journal of chromatography. Biomedical applications. 1992, Vol 575, Num 1, pp 75-85, issn 0378-4347Article

Pharmacokinetic properties of ranitidine in Chinese peopleYOA-PU HU, O; LI-HENG PAO; PING-HONG CHUNG et al.Acta gastro-enterologica belgica (Ed. multilingue). 1991, Vol 54, Num 5-6, pp 328-335, issn 0001-5644Article

Study on the bioequivalence of two ranitidine formulationsHILGENSTOCK, C; SCHMIEDEL, G; BÜHRENS, K.-G et al.Arzneimittel-Forschung. 1987, Vol 37, Num 8, pp 974-976, issn 0004-4172Article

Nizatidine in peptic ulcer disease: proceedings/1st. International symposium on nizatidine, Vienna, 11-12 October 1986BIANCHI PORRO, G; KEOHANE, P. P.Scandinavian journal of gastroenterology. Supplement. 1987, Vol 22, Num 136, issn 0085-5928, IV-88 pConference Proceedings

A review of the developments in H₂-receptor antagonist therapy: focus on famotidin, Seoul, 10 October 1988LANGMAN, M. J. S.Journal of international medical research. Supplement. 1989, Vol 17, Num 1, issn 0142-2596, 53 p.Conference Proceedings

On the mechanism of histamine H2 receptor activationLUQUE, F. J; ILLAS, F; POUPLANA, R et al.Molecular pharmacology. 1987, Vol 32, Num 4, pp 557-563, issn 0026-895XArticle

Quantitative structure-activity relationships in histamine H₂-agonists related to impromidine and arpromidineFRANKE, R; BUSCHAUER, A.European journal of medicinal chemistry. 1992, Vol 27, Num 5, pp 443-448, issn 0223-5234Article

Prodrugs of cimetidine with increased lipophilicity: N-acyloxymethyl and N-alkoxycarbonyl derivativesBUUR, A; BUNDGAARD, H.Acta pharmaceutica nordica. 1991, Vol 3, Num 1, pp 51-56, issn 1100-1801Article

Drug therapy : histamine₂-receptor antagonists-standard therapy for acid-peptic diseases (first of two parts)FELDMAN, M; BURTON, M. E.The New England journal of medicine. 1990, Vol 323, Num 24, pp 1672-1680, issn 0028-4793Article

Cancer occurrence in a cohort of patients treated with cimetidineMØLLER, H; LINDVIG, K; KLEFTER, R et al.Gut. 1989, Vol 30, Num 11, pp 1558-1562, issn 0017-5749Article

Nizatidine, and H₂-blocker: its metabolism and disposition in manKNADLER, M. P; BERGSTROM, R. F; CALLAGHAN, J. T et al.Drug metabolism and disposition. 1986, Vol 14, Num 2, pp 175-182, issn 0090-9556Article

High-performance liquid chromatographic assay for nizatidine, a new H₂ blocker, in human plasma and urine using disposable solid-phase extraction columnsCARLUCCI, G.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 2, pp 490-494, issn 0378-4347Article

High performance liquid chromatographic determination of ranitidine in human plasmaAL-KHAMIS, K. I; EL-SAYED, Y. M; AL-RASHOOD, K. A et al.Journal of liquid chromatography. 1995, Vol 18, Num 2, pp 277-286, issn 0148-3919Article

Cimetidin verbessert Therapie-/Toxizitätsverhältnis von Dapson bei Patienten in Dapson-Langzeit-behandlung = Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapyRHODES, L. E; TINGLE, M. D; PARK, B. K et al.H + G. Zeitschrift für Hautkrankheiten. 1995, Vol 70, Num 3, pp 210-214, issn 0301-0481Conference Paper

Reflections on the analytical pharmacology of histamine H₂-receptor antagonistsBLACK, J.Gastroenterology (New York, NY. 1943). 1993, Vol 105, Num 4, pp 963-968, issn 0016-5085Article